Evidence map›Paper›PMID 36123608›Full record

ArticleLipids in health and disease2022

ANGPTL3 is involved in kidney injury in high-fat diet-fed mice by suppressing ACTN4 expression.

Guanyu Li, Di Lu, Jingzhi Wang, Shuling Yue, Mei Tan, Ming Liu, Xia Gao

Open access · goldAbstract read
In one paragraph

Article in Lipids in health and disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. ANGPTL3 is a novel HDL component that regulates HDL function.Journal of translational medicine · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Guanyu Li *Nephrology Department, Guangzhou Women and Children's Medical Center, Guangdong Provincial Clinical Research Center for Child Health, Guangzhou Medical University, No. 318 Renmin Middle Road, Guangzhou City, 510623, China.
Di Lu *Nephrology Department, Guangzhou Women and Children's Medical Center, Guangdong Provincial Clinical Research Center for Child Health, Guangzhou Medical University, No. 318 Renmin Middle Road, Guangzhou City, 510623, China.
Jingzhi Wang *Nephrology Department, Guangzhou Women and Children's Medical Center, Guangdong Provincial Clinical Research Center for Child Health, Guangzhou Medical University, No. 318 Renmin Middle Road, Guangzhou City, 510623, China.
Shuling YueGuangzhou KingMed Diagnostics Group, Guangzhou City, 510623, China.
Mei TanNephrology Department, Guangzhou Women and Children's Medical Center, Guangdong Provincial Clinical Research Center for Child Health, Guangzhou Medical University, No. 318 Renmin Middle Road, Guangzhou City, 510623, China.
Ming LiuGuangdong Provincial Clinical Research Center for Child Health, Guangzhou Institute of Pediatrics, Guangzhou Women and Children's Medical Center, Guangzhou City, 510623, China.
Xia GaoNephrology Department, Guangzhou Women and Children's Medical Center, Guangdong Provincial Clinical Research Center for Child Health, Guangzhou Medical University, No. 318 Renmin Middle Road, Guangzhou City, 510623, China. gaoxiagz@vip.163.com.
Guangzhou Medical University · CNGuangzhou Women and Children Medical Center · CNKingmed Diagnostics · CN

Funding

National Natural Science Foundation of China 81660130Natural Science Foundation of Gansu Province 18JR3RA045Science and Technology Program of Guangzhou 202102010222
6 · The paper itself

Abstract

objectiveWe wanted to explore how angiopoietin-like 3 (ANGPTL3) impact hyperlipidemia-induced renal injury.

methodsANGPTL3 knockout mice and wild-type C57 mice were set up in four groups (N = 5) depending on a normal or 60% high-fat diet: wild-type with normal diet (WT), angptl3-/- with normal diet (KO), wild-type + high-fat diet (WT + HF) and angptl3-/- + high-fat diet (KO + HF). The detection time points were the 9th, 13th, 17th and 21st weeks after modeling. Serum lipid and urinary protein levels of mice in each group were detected, and pathological changes in the kidney were analyzed. Moreover, the expression of ANGPTL3, α-actinin-4 (ACTN4), CD2-associated protein (CD2AP) and podocin was tested in the glomerulus by immunohistochemistry (IHC).

resultsIn the WT + HF group, hyperlipidemia and proteinuria could be observed at the 9th week and were gradually aggravated with time. Compared with WT + HF mice, the levels of serum lipids and proteinuria in KO + HF mice were significantly reduced, and the width of podocyte foot processes (FPs) fusion was also markedly improved. The IHC results suggested that in WT + HF mice, the expression of ANGPTL3 was significantly enhanced. After modeling, ACTN4 expression was markedly weakened in the glomeruli of WT + HF mice. Different to WT mice, ACTN4 expression was not observed obviously change in KO + HF mice. Compared with the normal diet group, the expression of podocin showed a decline in WT mice treated with high-fat diet and showed a significant difference from the 17th week. In addition, podocin expression in KO + HF glomeruli was also found to be weak but not significantly different from that in WT + HF glomeruli at the four time points. The expression of CD2AP showed similar results among the four groups.

conclusionANGPTL3 could play a role in the mechanism of hyperlipidemia-associated podocyte injury via ACTN4.

Indexed as

Diet, High-FatHyperlipidemiasActininAngiopoietin-Like Protein 3Angiopoietin-like ProteinsAngiopoietinsAnimalsKidneyLipidsMiceMice, KnockoutProteinuriaActininAngiopoietin-Like Protein 3Angiopoietin-like ProteinsAngiopoietinsAngptl3 protein, mouseLipidsACTN4ANGPTL3Hyperlipidemia renal injuryPodocinPodocyte injury

Identifiers

PMID36123608
PMCPMC9487085
OpenAlexW4296457245

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.